抗高热治疗减少脑出血周围水肿低密度
这项回顾性研究基于前瞻性登记数据库,纳入795例自发性脑出血患者,分析发病24小时内体温变化与血肿周围低密度及3个月预后的关系。结果显示,24小时内体温下降使良好预后可能性增加11倍;接受抗高热治疗的患者中31.8%观察到体温下降、较低的血肿周围低密度体积及良好预后。
要点
- 早期抗高热治疗可能改善自发性脑出血患者预后
- 24小时内体温下降与良好预后独立相关
- 血肿周围低密度体积与体温变化相关
核心结论
- 对于基线腋温≥37.5°C的自发性脑出血患者,早期给予抗高热治疗可使约三分之一患者获得良好预后。
研究设计与样本
- 回顾性研究,基于前瞻性登记数据库,从1100例患者中纳入795例符合条件的自发性脑出血患者。
主要发现
- 24小时内体温下降使良好预后可能性增加11倍。
- 接受抗高热治疗的患者中31.8%观察到体温下降、较低的血肿周围低密度体积及良好预后。
关键数值与推荐
- 体温≥37.5°C的患者接受抗高热药物治疗至少48小时。
- 主要结局为3个月良好预后,关联指标包括24小时体温变化和血肿周围低密度。
临床怎么用
- 对自发性脑出血且腋温≥37.5°C的患者,可考虑早期抗高热治疗以改善预后。
局限性
- 回顾性研究设计可能引入选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the effect on perihematomal hypodensity and outcome of a decrease in body temperature in the first 24 hours in patients with intracerebral hemorrhage (ICH). METHODS: In this retrospective study on a prospectively registered database, among the 1,100 patients, 795 met all the inclusion criteria. Temperature variations in the first 24 hours and perihematomal hypodensity (PHHD) were recorded. Patients ≥37.5°C were treated with antihyperthermic drugs for at least 48 hours. The main objective was to determine the association among temperature variation, PHHD, and outcome at 3 months. RESULTS: The decrease in temperature in the first 24 hours increased the possibility of good outcome 11-fold. Temperature decrease, lower PHHD volume, and a good outcome were observed in 31.8% of the patients who received antihyperthermic treatment. CONCLUSION: The administration of early antihyperthermic treatment in patients with spontaneous ICH with a basal axillary temperature ≥37.5°C resulted in good outcome in a third of the treated patients.
引用
- Hervella P, Rodríguez-Yáñez M, Pumar JM, et al. Antihyperthermic treatment decreases perihematomal hypodensity. Neurology. 2020. PMID: 32221027. doi:10.1212/WNL.0000000000009288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。